Which Breast Cancer Treatment Should You Choose? at www.ResourcesForBreastCancer.com
ResourcesForBreastCancer.com :: Alternative Forms Of Medicine For Cancer Patient

Alternative Forms Of Medicine For Cancer Patient


Alternative forms of medicine like:

Acupuncture can be used for providing pain relief.

Herbal Medicine helps strengthen the body's ability to eliminate cancer cells. They do not however cure cancer, but can definitely prolong the life of a person suffering from cancer.

Homeopathy is effective in providing relief from the side effects of chemotherapy and radiation.

Mind and Body Treatment focuses on a persons emotions, behaviour and faith. It is believed that a person must maintain a positive attitude and live a life free of mental and emotional stress. Massage and reflexology have also been found to be effective in strengthening cells and promoting the release of anti-cancer hormones in the body. The Mind and Body treatment has been found to be very effective and powerful in dealing with cancer, and perhaps even preventing it.

Nutrition and Diet has been found to be effective in preventing tissue and cell damage and ensuring the proper immune function of the body.

Traditional Chinese Medicine has been found to be effective in providing relief from the side effects of the conventional treatments of cancer. Practitioners of this form of medicine recommend the use of herbs like Asian Ginseng, Astragalus and Dong Quai.


About the Author: Article submited By John D. Samara On the behalf of www.childcancerandyou.org. John D. Samara is a journalist and presently working in remote areas of asian sub continents for awareness on Cancer. Global cancer concern india is a ngo in india serving cancer suffering people for cure of different types of cancer like child cancer, throat cancer, breast cancer, bone cancer, prostat cancer etc. For making donations kindly visit www.childcancerandyou.org Donation for Cancer Patients , Online Donations, Donate Online for Cancer Patients, NGO india

Source: www.isnare.com

Written by: John J

Updates and Recent News

How Multiple Copies Of A Gene Affect Metastasis?
Scientists at UT Southwestern Medical Center have for the first time described how multiple copies of a gene are responsible for metastases in early-stage breast cancer and poor prognosis for patients. As per a research findings published in this week's issue of the Proceedings of the National Academy of Sciences, the gene, called uPAR, offers a promising target for therapeutic drugs to stop or slow the progression of the disease and could serve as a screening tool for assessing which types of drugs a patient will respond to....
To Read More...

Research Data From Institute Of Cancer Research Update Understanding Of Breast Cancer Prevention
Fresh data on breast cancer are presented in the report 'Pregnancy in the mature adult mouse does not alter the proportion of mammary epithelial stem/progenitor cells.' According to a study from London, the United Kingdom, "In humans, an early full-term pregnancy reduces lifetime breast cancer risk by up to 50% whereas a later pregnancy (>35 years old) can increase lifetime risk. Several mechanisms have been suggested, including changes in levels of circulating hormones, changes in the way the breast responds to these hormones, changes in gene expression programmes which may alter susceptibility to transformation and changes to mammary stem cell numbers or behaviour." "Previous studies have shown that the mammary tissue isolated from bot.
To Read More...

Two Treatments Similar In Breast Cancer
Results from a clinical trial comparing the effectiveness of the drugs paclitaxel and docetaxel, delivered over two different dosing schedules, showed that both drugs - regardless of the dosing schedules tested in this trial - provided similar benefits for women with stage II or III, operable breast cancer. However, more women treated with docetaxel than with paclitaxel experienced serious side effects from their therapy. The trial was led by the Eastern Cooperative Oncology Group in collaboration with the Cancer and Leukemia Group B, North Central Cancer Treatment Group (NCCTG), and the Southwest Oncology Group. The National Cancer Institute (NCI), part of the National Institutes of Health, supported this Phase III randomized clinical trial. The results were presented at the San Antonio Breast Cancer Symposium on December 8, 2005. ..
To Read More...